1.
McLaughlin T, Rakestraw D, Okut H, Ablah E. Adverse Events Reported Following RSV Prefusion F Protein Vaccines Administration Among Approved Populations: A Cross-Sectional Study. kjm [Internet]. 2025 Dec. 16 [cited 2025 Dec. 29];18(6):129-33. Available from: https://journals.ku.edu/kjm/article/view/23980